These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11411192)

  • 1. Treating the substance-abusing suicidal patient.
    Cornelius JR; Salloum IM; Lynch K; Clark DB; Mann JJ
    Ann N Y Acad Sci; 2001 Apr; 932():78-90; discussion 91-3. PubMed ID: 11411192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.
    Nordentoft M
    Dan Med Bull; 2007 Nov; 54(4):306-69. PubMed ID: 18208680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
    Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
    Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR; Bukstein OG; Wood DS; Kirisci L; Douaihy A; Clark DB
    Addict Behav; 2009 Oct; 34(10):905-9. PubMed ID: 19321268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
    Cornelius JR; Bukstein OG; Birmaher B; Salloum IM; Lynch K; Pollock NK; Gershon S; Clark D
    Addict Behav; 2001; 26(5):735-9. PubMed ID: 11676382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts.
    Montgomery DB; Roberts A; Green M; Bullock T; Baldwin D; Montgomery SA
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(4):211-5. PubMed ID: 7888419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder.
    Garlow SJ; Kinkead B; Thase ME; Judd LL; Rush AJ; Yonkers KA; Kupfer DJ; Frank E; Schettler PJ; Rapaport MH
    J Psychiatr Res; 2013 Sep; 47(9):1199-203. PubMed ID: 23786912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in clinical predictors of suicidal acts after major depression: a prospective study.
    Oquendo MA; Bongiovi-Garcia ME; Galfalvy H; Goldberg PH; Grunebaum MF; Burke AK; Mann JJ
    Am J Psychiatry; 2007 Jan; 164(1):134-41. PubMed ID: 17202555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Perel JM; Thase ME; Black A
    Arch Gen Psychiatry; 1997 Aug; 54(8):700-5. PubMed ID: 9283504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal relationships between substance use and disorders and suicidal ideation and suicide attempts in the Collaborative Study of the Genetics of Alcoholism.
    Agrawal A; Tillman R; Grucza RA; Nelson EC; McCutcheon VV; Few L; Conner KR; Lynskey MT; Dick DM; Edenberg HJ; Hesselbrock VM; Kramer JR; Kuperman S; Nurnberger JI; Schuckit MA; Porjesz B; Bucholz KK
    J Affect Disord; 2017 Apr; 213():96-104. PubMed ID: 28213124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.